DexCom and Lilly Are Joining for the Better of All with Diabetes
More About This Development Agreement
Both companies expect to combine Dexcom’s continuous glucose monitoring (CGM) and Lily’s smart insulin delivery devices. They will do this in order to improve the future of management of diabetes. The Connected Diabetes Ecosystem of Eli Lily and Company promises to drive a notable step forward when it comes to diabetes management. According to the CEO and President of Dexcom, Kevin Sayer they believe that connected system over time will become the standard of care.The Aim of the Companies
He says that by combining technology, devices, and drugs, they can come to solutions which adapt to each’s unique needs when it comes to diabetes management. Also at the same time, they will provide compelling advancements for payers and physicians. The aim of the companies is to offer a comprehensive solution to those who have diabetes. Devices like apps, drugs, CGM, insulin pumps and smartpens will be aimed to improve outcomes. The clinical trials should start by the end of this year.The Opinion of the President of Lilly USA and Lily Diabetes
According to the president Enrique Conterno, the Connected Diabetes Ecosystem does not relies only on the core diabetes expertise of Lilly. It relies also on the strength on their key partners like Dexcom. Enrique Conterno says that Dexcom will be a crucial collaborator in this mission. Mission to improve outcomes and lower the daily burden for individuals with diabetes. DexCom with headquarters in San Diego, CA is a company which is dedicated to helping people have better management over their diabetes. It is doing that by marketing and developing CGM tools and products for pediatric and adult patients. Moreover, with the incredible performance, lifestyle flexibility and patients comfort, users rank DexCom highest in customer loyalty and satisfaction. We hope that this collaboration will have change a lot of things for those with diabetes.
Leave a Comment